Integrated and Standardized NGS Workflows for Personalised Therapy
Recent Posts
- OECI dedicates a Special Edition Newsletter to Instand-NGS4P
- Event announcement: EASI-Genomics Workshop on Implementing Genomic Research Projects
- Contract Award for PCP Phase 2 – Prototype Development
- New CEN Technical Specifications on NGS Workflow enter final technical commenting period
- Consortium Meeting, 22-23.06.2022, Florence
Important Events & Dates:
Deadline for Submission of Phase 1 Deliverables – 15th of August 2022 View information
Prior Information Notice (PIN) published on 28.12.2020 Download PDF Lot Information
Open Market Consultation (OMC)
Partnering Platform available View Partnering Platform
Request for Tenders – published on the 19th of October 2021 View Request for Tenders
Tendering Webinar 3rd November 2021 15:00-17:00 CET View recording
Deadline for Tenders´ Receipt – 19th of December 2021
A Pre-Procurement Project for improving cancer patients’ benefit from Next Generation Sequencing (NGS) by developing an integrated and standardized NGS workflow and integrating information from cancer gene testing, pharmocogenetics testing and e-medication in proper presentation to medical doctors for supporting therapy decision making at bedside.
This 65 month H2020 project started in January 2020.
The maximum Grant Agreement amount is €10.998.128,16
Cofunded by the European Union under Grant Agreement No. 874719